Last reviewed · How we verify
Acetaminophen 500mg
At a glance
| Generic name | Acetaminophen 500mg |
|---|---|
| Also known as | Tempra® 500mg |
| Sponsor | Universidad Autonoma de Nuevo Leon |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Musculoskeletal Outcomes Using Tylenol/Ibuprofen vs. Oral Steroids in New Injuries (PHASE4)
- Suzetrigine Versus Usual-care Opioids for Postop Pain in Sports (PHASE4)
- Traditional vs. Posterior Nasal Radiofrequency Ablation for Chronic Rhinitis (NA)
- Reduced Opioid Prescription After Laparoscopic Hysterectomy (NA)
- Meloxicam in Mohs Micrographic Surgery (PHASE4)
- Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma (PHASE1, PHASE2)
- A Study of Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery (PHASE3)
- Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acetaminophen 500mg CI brief — competitive landscape report
- Acetaminophen 500mg updates RSS · CI watch RSS
- Universidad Autonoma de Nuevo Leon portfolio CI